The Longview: Fireside Chat with Biodexa CEO Stephen Stamp

Today's interview with Stephen Stamp, CEO of Biodexa Pharmaceuticals PLC NASDAQ:BDRX is about the Company's lead program, eRapa in Familial Adenomatous Polyposis (FAP), a genetic disease of the lower GI tract for which the only current remedy is surgical removal of the colon and/or rectum.Key takea…